Debora Barton - Jul 5, 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Chief Medical Officer
Signature
/s/ Debora Barton
Stock symbol
TCRX
Transactions as of
Jul 5, 2022
Transactions value $
$0
Form type
4
Date filed
7/7/2022, 07:57 AM
Next filing
Feb 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (right to buy) Award $0 +150K $0.00 150K Jul 5, 2022 Voting Common Stock 150K $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following July 5, 2022, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the Issuer.